Voyager Therapeutics (VT6.F) Q3 2024 Earnings

6AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.41
0.11
0.63
1.15

Details

Expected EPS
-0.37444842542
Actual EPS
-0.1647468
Surprise EPS
0.21
Surprise Percent
+56%

Description

Voyager Therapeutics (VT6.F) has reported earnings of -0.1647468 per share for Q3 2024.

0 Comments

Share your thoughts